Sentences with phrase «of diagnostic samples»

(1) Trapping and anesthetizing of the animals pursued, collection of diagnostic samples, attaching or surgically implanting monitoring or recognition devices or markings, and providing veterinary care or euthanasia, as required, for the health, safety, and humane treatment of the animals.

However, in the event of a diagnostic sample not being available, we are still able to detect ITDs.

Not exact matches

«Liquid biopsies are far less invasive than traditional biopsies, a development that not only benefits our patients through a simplified diagnostic procedure but also by significantly enhanced analysis of samples taken,» said Dr. Stanley Hamilton, professor of Pathology and division head of Pathology and Laboratory Medicine at MD Anderson, in a statement.

The gardener will not always be able to determine the cause of the problem while investigating, and samples may need to be sent to a university or diagnostic laboratory for further testing.

If a blood test comes back with a high - risk result, your practitioner may suggest an amniocentesis, a diagnostic test that takes a sample of amniotic fluid from the uterus for further testing.

These findings highlight the importance of systematic study of diagnostic criteria in representative samples of the general population.

The company wanted to use it as a diagnostic marker for disease: If synthetic versions of antibodies could be tagged with aequorin in the lab, then whenever they matched up with an antigen (or surface protein) of a specific pathogen in blood or tissue, the sample would glow.

«Future studies with larger sample sizes combined with machine learning analysis may further aid the diagnostic and prognostic value of structural MRI.»

Lead author Professor Debra Skene from the University of Surrey, said: «Our results show that if we want to develop a diagnostic test for a disease, it is imperative to take the time of day when taking blood samples into account, since this has a significant effect on metabolism.

Not long after their 2008 finding, Weidhaas and Slack devised a simple diagnostic test that uses blood or saliva samples to detect the presence of the KRAS - variant.

Investigators sent tissue and blood samples to Michael McIntosh at the U.S. Department of Agriculture's Foreign Animal Disease Diagnostic Laboratory at the Plum Island Animal Disease Center in Greenport, N.Y. McIntosh says he was surprised to find that the tissue samples also contained the Reston strain, which had not been previously identified in swine.

The authors note that prior studies have reported elevated levels of distress among people with cancer, but they vary in quality due to small sample sizes, different diagnostic criteria and assessment standards, and an over-representation of women with breast cancer.

This is important because if you are trying to discover or use new diagnostic tests, you need to be able to get the same result regardless of where you send blood samples.

Michael A. Yokell, Sc.B., of the Stanford University School of Medicine, Stanford, Calif., and colleagues analyzed the 2010 Nationwide Emergency Department Sample using diagnostic codes to define opioid overdoses.

The latter, presented by Eric Lander of the Broad Institute in Cambridge, Massachusetts, would systematically sequence tumor samples for mutations involved in cancer to speed up the search for new drugs and diagnostics.

«Researchers isolate novel urinary biomarkers that may indicate adrenal cancer: A quartet of metabolites found in urine samples may help solve diagnostic and treatment dilemmas associated with clinically silent adrenal masses.»

The study used an age - and IQ - matched sample of school - aged youth diagnosed with ASD to assess sex differences according to the standard clinical tests including the Autism Diagnostic Observation Schedule (ADOS) and the Autism Diagnostic Interview - Revised (ADI - R), as well as parent reported autistic traits and adaptive skills.

Filter paper is currently used for the storage and transport of dried blood samples, however there is very little research on similarly simple and inexpensive methods for the transport of other diagnostic fluids.

New diagnostic techniques revealed traces of blood (inset, in blue) in microscopic samples from ancient African artifacts such as this one.

«In the past, science has focused on identifying the pathogen someone is infected with in the blood or other sample,» said lead author Thomas Burke, Ph.D., director of technology advancement and diagnostics at the DCAGPM.

A potentially compelling argument against the surprisingly high rates of autism found in this sample was the wide discrepancy between children and adults who met the diagnostic criteria.

A sample of an animal's breath is much easier to obtain, and researchers believe it contains as many diagnostic molecules as blood, just at lower concentrations that are much harder to detect and analyze.

«Some of our collaborators are just sending us samples and we're helping with the diagnostic testing.

The researchers developed a diagnostic system they dubbed the DNA Endonuclease Targeted CRISPR Trans Reporter, or DETECTR, for quick and easy point - of - care detection of even small amounts of DNA in clinical samples.

An artificial neural network is used to transform low - resolution microscopic images of samples into high - resolution images, revealing more details of the sample, which could be crucial for pathology and medical diagnostics.

Moreover, he believes that investment in technologies such as chip - based methods to rapidly test blood or tissue samples for the presence of anthrax or smallpox would speed the development of related diagnostic tools for regular diseases.

The researchers also found that the specific strain of Legionella isolated from Flint residences as part of FACHEP's sampling in 2016 is not readily detected by common diagnostic tests for Legionella.

In addition, although we used a validated method to define diagnostic categories for both self - respondents and respondents represented by a proxy, the proportion of the HRS sample represented by a proxy declined significantly between 2000 and 2012 (from 12.5 % to 8.2 % unweighted), likely due in part to a change in HRS field procedures between these 2 waves.

Scientists tested the sensitivity of several diagnostic technologies using samples drawn from participants in MHRP and Thai Red Cross's RV254 acute infection study, in which individuals in the acute HIV infection stage are identified and immediately begin ART, some within days of HIV exposure.

The objective of this study is to validate the diagnostic performance and practical feasibility of massively parallel genomic sequencing for the non-invasive prenatal assessment of trisomy 21 in a large number of pregnancies that have undergone conventional screening and were clinically indicated for definitive testing by amniocentesis or chorionic villus sampling.

HLI has signed an agreement with Metabolon Inc., a diagnostic products and services company offering the biochemical profiling platform, to capture this information from each of the genomic samples that HLI is collecting.

To this end, we classify a sample of 4683 molecular cloud clumps identified from the Bolocam Galactic Plane Survey by combining observational diagnostics of star formation activity from a variety of Galactic plane surveys.

Potential risks and uncertainties include, but are not limited to, the risks: a) deCODE's previously discovered at - risk variants may not be sufficiently informative to have diagnostic value; b) Illumina's BeadLab infrastructure may not support sufficiently the high sample throughput envisioned by the parties; c) Illumina may not manufacture HumanHap BeadChips in adequate quantity or quality; d) the companies may not see an increased customer base as a result of the collaboration, as well as other risks and uncertainties detailed from time to time in deCODE's or Illumina's filings with the Securities and Exchange Commission.

Our present capacity is limited, so the submission of samples is coordinated and prioritized by CIMMYT and ICARDA, in collaboration with national rust diagnostic laboratories and research institutes.

Researchers have devised a new CRISPR - based tool that will detect very small amounts of virus and bacteria in blood and urine samples for diagnostic tests.

We believe that by integrating these technologies, healthcare workers in remote regions equipped with microscopy - enabled mobile phones could take diagnostic images of patient samples (blood, sputum, etc.), perform on - board image analysis and / or wirelessly transmit those images off - site for medical record keeping, epidemic tracking, or further analysis by clinical experts.

This supports the overall goal of using such diagnostic test in the field to test bodily samples including urine, blood or saliva.

SHERLOCK is an extremely sensitive CRISPR - based diagnostic tool that scientists and medical practitioners can use to detect even the faintest presence of virus and bacteria from a patient's blood or urine sample.

With the growing use of fluorescent stains in sample preparation to increase diagnostic sensitivity and specificity, we furthermore sought to incorporate fluorescent imaging capabilities into our mobile microscopy system and test the use of digital image processing for image analysis.

Most published studies entailed small number of subjects; well - designed studies with larger sample sizes are needed to ascertain how this test can reduce clinical diagnostic uncertainty or impact treatment planning.

Why It Matters: One of the most powerful diagnostic and analytical tools in chemistry and materials science, MAS NMR spectroscopy provides high spectral resolution and detailed structural information about a sample on an atomistic or molecular level and allows scientists to follow changes over time regardless of whether the sample is a solid or a liquid or a mixture of solid, liquid, and gas phases.

He also pioneered the development of microfabricated capillary electrophoresis devices and microfabricated integrated sample preparation and detection methods for lab - on - a-chip analysis that are being applied to DNA sequencing, diagnostics, forensics, pathogen detection and space exploration.

Using nanopore sequencing, metagenomic detection of viral pathogens directly from clinical samples was performed within an unprecedented < 6 hours sample - to - answer turnaround time and in a timeframe amenable for actionable clinical and public health diagnostics.

U.S. and U.N. officials have told the AP that Brazil has so far probably shared fewer than 20 samples when experts say hundreds or thousands of samples are needed to track the virus» evolution and develop accurate diagnostics and effective drugs and vaccines.

Esko is collaborating with Zacharon Pharmaceuticals, a San Diego - based biotechnology company, to develop a commercial diagnostic assay for differentiating forms of MPS from urine and blood samples, a screening test for newborns and a tool for measuring the biochemical response of MPS patients to existing and novel therapies.

Sansbury and Kmiec said that while their work with their CRISPR - Cpf1tool has confirmed its usefulness for reliably editing DNA samples that are part of a diagnostic test, it is not yet fully developed as a therapeutic tool for directly treating disorders that would involve repairing or removing malfunctioning genes in humans, animals or plants.

We prospectively identified all individuals over a 12 - month period who had at least one MRSA - positive sample processed by a routine diagnostic microbiology laboratory in the East of England, which received samples from three hospitals and 75 general practitioner (GP) practices.

Those parameters might be much more important for a particular choice of technology when sample material, e.g., from cancer patients, is limited or when sequencing time is critical, e.g., in a cancer diagnostic setting.

Same - day diagnostic and surveillance data for tuberculosis via whole genome sequencing of direct respiratory samples.

However, these approaches have not yet delivered all that they promised, partly due to the inherent genetic variability between patient samples, but also because the diagnostic / prognostic accuracy of the cancer signatures identified tends to be linked to the patient cohorts from which those signatures were obtained.